Boardroom Alpha
Boardroom Alpha
NVEC · Current Report (Form 8-K) · Filed August 10, 2026

Nve Corp — Current Report (Form 8-K)

Form
8-K
Filed
August 10, 2026
Period
Aug 6, 2026
Ticker
NVEC
Accession
0001376474-26-000547
Boardroom Alpha · Filing insights

CEO succession completed: Eames named CEO; Baker retires as CEO but remains on the board. Board expands to seven directors.

About Nve Corp
Market cap
$517M
1Y TSR
+95.3%
3Y TSR
+19.6%
Board grade
C+
Sector
Technology
CEO
Peter G. Eames
Last annual meeting: Aug 6, 2026 · View full Nve Corp profile →
NVE Corp - Form 8-K SEC filing

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)  August 6, 2026

Picture 1
NVE Corporation
(Exact name of registrant as specified in its charter)

 

Minnesota

000-12196

41-1424202

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

 

 

11409 Valley View Road, Eden Prairie, Minnesota

55344

(Address of principal executive offices)

(Zip Code)


Registrant’s telephone number, including area code (952) 829-9217

                                                                                                                                
(Former name or former address, if changed since last report.)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading symbol(s)

Name of each exchange on which registered

Common Stock, $0.01 par value

NVEC

The NASDAQ Stock Market, LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  


 

Item 5.07 Submission of Matters to a Vote of Security Holders.

Our 2026 Annual Meeting of Shareholders was held August 6, 2026, for the following purposes: (1) elect seven directors; (2) advisory approval of named executive officer compensation; and (3) ratify the selection of Boulay PLLP as our independent registered public accounting firm for the fiscal year ending March 31, 2027.

 

Proxies for the meeting were solicited pursuant to Section 14(a) of the Exchange Act. There were 4,837,166 shares of common stock entitled to vote with a majority represented at the meeting. The Board of Directors recommended a vote for each of the director nominees and for Proposals 2 and 3. There was no solicitation in opposition.

 

Abstentions for Proposals 1 and 2 did not affect the results. Abstentions for Proposal 3 had the effect of a negative vote.

 

The final voting results were as follows:

 

 

Number of Shares

Voted For

 

 

Withheld

 

 

  Abstain  

1. 

Elect seven directors:

   

 

 

     Daniel A. Baker

 

3,058,859

 

 

 

37,416

 

 

 

-

 

     Peter G. Eames

 

3,081,308

 

 

 

14,967

 

 

 

-

 

     Terrence W. Glarner

 

2,889,674

 

 

 

206,601

 

 

 

-

 

     Patricia M. Hollister

 

3,050,866

 

 

 

45,409

 

 

 

 

     James W. Bracke

 

3,067,479

 

 

 

28,796

 

 

 

 

     Kelly Wei

 

3,073,306

 

 

 

22,969

 

 

 

 

     Carolyn W. Valentine

 

3,081,279

 

 

 

14,996

 

 

 

 

 

Voted For

 

 

Voted Against

 

 

Abstain

2.

Advisory approval of named executive officer compensation.

 

 

3,011,073

 

 

 

73,720

 

 

 

11,480

 

 

Voted For

 

 

Voted Against

 

 

  Abstain  

3.

Ratify the selection of Boulay PLLP as our independent registered public accounting firm for the fiscal year ending March 31, 2027.

   

 

3,876,455

 

 

 

3,389

 

 

 

11,855

 

Based on the results, each director nominee was elected, named executive officer compensation was approved, and the selection of our independent registered public accounting firm was ratified.

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

In accordance with the Company’s CEO succession plan described in our Proxy Statement on Schedule 14A and Item 5.02 of our Current Report on Form 8-K, both filed on June 22, 2026, Daniel A. Baker retired as president and chief executive officer effective at the Shareholders’ Meeting. Dr. Baker was reelected to the Board of Directors and elected chairman of the board. Peter G. Eames was elected to the Board and appointed president and chief executive officer.

 

Caroyln W. Valentine was elected to the Board for the first time and appointed to the Compensation and Nominating/Corporate Governance committees. The election of Dr. Eames and Ms. Valentine increased our board size from five to seven directors.

 

Biographical information for Dr. Eames and Ms. Valentine is included in our proxy statement on Schedule 14A filed June 22, 2026, and is incorporated by reference herein. Compensation information for Dr. Eames was disclosed in our Current Report on Form 8-K filed June 22, 2026, and is incorporated by reference herein.

 

Neither Dr. Baker nor Dr. Eames have been appointed to any committee of the Board, there are no arrangements or understandings between Dr. Eames and any other person pursuant to which Dr. Eames was selected as a director, and Dr. Eames does not have any direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

 

2


 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 

Date  August 10, 2026

NVE CORPORATION
(Registrant)

 

 

 /s/ PETER G. EAMES
Peter G. Eames
President and CEO

 

 

 

 

 

 

 

 

 

3


 

INDEX TO EXHIBITS

Exhibit #

Description

104

Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

 

 

 

 

 

 

 

4

 

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Nve Corp (NVEC)

Reference

Frequently asked questions

When did Nve Corp file this 8-K?
Nve Corp (NVEC) filed this Current Report (Form 8-K) with the SEC on August 10, 2026. The accession number assigned by EDGAR is 0001376474-26-000547.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
CEO succession completed: Eames named CEO; Baker retires as CEO but remains on the board. Board expands to seven directors. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Nve Corp's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Nve Corp has filed under CIK 724910, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer